SHENZHEN, China, March 3 China NepstarChain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), thelargest drugstore chain in China based on the number of directly operatedstores, today announced that the Board of Directors has declared a cashdividend of US$0.28 per American Depositary Share (ADS). The cash dividend ispayable on or around May 3, 2010, to shareholders of record as of the close ofbusiness on April 2, 2010.
Mr. Ian Wade, Chief Executive Officer of China Nepstar, commented, "We arepleased that our improved operation and strong free cash-flow generationenable us to continue with dividend payment. This payment is consistent withour balanced growth strategy, which we believe allows us to maximize long-termshareholder value."
About China Nepstar Chain Drugstore Ltd.
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China's largest retaildrugstore chain based on the number of directly operated stores. As ofDecember 31, 2009, the Company had 2,479 stores across 71 cities, oneheadquarter distribution center and 12 regional distribution centers in China.Nepstar uses directly operated stores, centralized procurement and a networkof distribution centers to provide its customers with high-quality,professional and convenient pharmacy services and a wide variety of othermerchandise, including OTC drugs, nutritional supplements, herbal products,personal care products, family care products, and convenience productsincluding consumables. Nepstar's strategy of centralized procurement,competitive pricing, customer loyalty programs and private label offerings hasenabled it to capitalize on the robust economic growth in China and to takeadvantage of the demographic trend in China to achieve a strong brand andleading market position. For further information, please go tohttp://www.nepstar.cn .
Safe Harbor Statement
This press release contains forward-looking statements. These statementsconstitute "forward-looking" statements within the meaning of Section 21E ofthe Securities Exchange Act of 1934, as amended, and as defined in the U.S.Private Securities Litigation Reform Act of 1995. These forward-lookingstatements can be identified by terminology such as "will," "expects,""anticipates," "future," "intends," "plans," "believes," "estimates" andsimilar statements. Among other things, the quotations from management in thispress release and the Company's strategic operational plans and businessoutlook, contain forward-looking statements. Such statements involve certainrisks and uncertainties that could cause actual results to differ materiallyfrom those in the forward-looking statements. Further information regardingthese and other risks is included in the Company's filings with the U.S.Securities and Exchange Commission, including its annual report on Form 20-F.The Company does not undertake any obligation to update any forward-lookingstatement as a result of new information, future events or otherwise, exceptas required under applicable law.For more information, please contact: In China: Lucia Qian China Nepstar Chain Drugstore Ltd. Vice President, IR Tel: +86-755-2641-4065 Email: [email protected]
In the United States: Dixon Chen Grayling Investor Relations Tel: +1-646-284-9403 Email: [email protected]
Ivette Almeida Grayling Media Relations Tel: +1-646-284-9455 Email: [email protected]
SOURCE China Nepstar Chain Drugstore Ltd.